Assignee
KYMAB LTD
GB·102 granted patents·96 pending applications·1,139 citations·filing 2013–2025
Top patents by PatentIndex Score
198 records- 0198US9434782B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Sep 6, 2016·31 cites·8 claims
- 0298US9234043B1Anti-human OX40L antibodiesKYMAB LTD·Filed 2015·Granted Jan 12, 2016·21 cites·20 claims
- 0398US9139653B1Anti-human OX40L antibodies and methods of treatmentKYMAB LTD·Filed 2015·Granted Sep 22, 2015·38 cites·27 claims
- 0498US8883157B1Targeting rare human PCSK9 variants for cholesterol treatmentKYMAB LTD·Filed 2013·Granted Nov 11, 2014·39 cites·30 claims
- 0597US10226033B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2017·Granted Mar 12, 2019·13 cites·22 claims
- 0697US10165763B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Jan 1, 2019·13 cites·16 claims
- 0797US9938357B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Apr 10, 2018·21 cites·23 claims
- 0897US9938358B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Apr 10, 2018·19 cites·23 claims
- 0997US9924705B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Mar 27, 2018·20 cites·36 claims
- 1097US9896516B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Feb 20, 2018·20 cites·11 claims
- 1197US9617338B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Apr 11, 2017·78 cites·20 claims
- 1297US9567399B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Feb 14, 2017·96 cites·21 claims
- 1397US9512229B2Synergistic combinations of OX40L antibodies for the treatment of GVHDKYMAB LTD·Filed 2016·Granted Dec 6, 2016·12 cites·30 claims
- 1497US9505827B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Nov 29, 2016·27 cites·10 claims
- 1597US9439963B2Methods of treating anaemiaKYMAB LTD·Filed 2016·Granted Sep 13, 2016·11 cites·29 claims
- 1697US9139648B1Precision medicine by targeting human NAV1.9 variants for treatment of painKYMAB LTD·Filed 2015·Granted Sep 22, 2015·16 cites·24 claims
- 1797US9045545B1Precision medicine by targeting PD-L1 variants for treatment of cancerKYMAB LTD·Filed 2014·Granted Jun 2, 2015·48 cites·15 claims
- 1896US10774155B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2018·Granted Sep 15, 2020·9 cites·26 claims
- 1996US10604576B2Antibodies and immunocytokinesKYMAB LTD·Filed 2017·Granted Mar 31, 2020·25 cites·14 claims
- 2096US10064398B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2014·Granted Sep 4, 2018·14 cites·25 claims
- 2196US9957323B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted May 1, 2018·27 cites·26 claims
- 2296US9868790B2Synergistic combinations of OX40L antibodies for the treatment of GvHDKYMAB LTD·Filed 2017·Granted Jan 16, 2018·11 cites·29 claims
- 2396US9868789B2Synergistic combinations of OX40L antibodies for the treatment of GvHDKYMAB LTD·Filed 2017·Granted Jan 16, 2018·11 cites·19 claims
- 2496US9788534B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Oct 17, 2017·18 cites·19 claims
- 2596US9428578B2Methods of treating anaemiaKYMAB LTD·Filed 2016·Granted Aug 30, 2016·8 cites·30 claims
- 2696US9303089B2Methods of treating anaemiaKYMAB LTD·Filed 2015·Granted Apr 5, 2016·9 cites·17 claims
- 2796US9187562B1Methods for treating anaemiaKYMAB LTD·Filed 2015·Granted Nov 17, 2015·12 cites·17 claims
- 2896US9109034B1Precision medicine by targeting PD-L1 variants for treatment of cancerKYMAB LTD·Filed 2015·Granted Aug 18, 2015·21 cites·15 claims
- 2996US9034332B1Precision medicine by targeting rare human PCSK9 variants for cholesterol treatmentKYMAB LTD·Filed 2014·Granted May 19, 2015·29 cites·27 claims
- 3096US8945560B1Method of treating rheumatoid arthritis using antibody to IL6RKYMAB LTD·Filed 2014·Granted Feb 3, 2015·24 cites·19 claims
- 3195US10730930B2Antibodies, variable domains and chains tailored for human useKYMAB LTD·Filed 2017·Granted Aug 4, 2020·9 cites·15 claims
- 3295US10251377B2Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodiesKYMAB LTD·Filed 2014·Granted Apr 9, 2019·17 cites·30 claims
- 3395US10149462B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Dec 11, 2018·15 cites·24 claims
- 3495US9416180B1Precision medicine by targeting VEGF-A variants for treatment of diabetic macular edema and branch retinal vein occlusionKYMAB LTD·Filed 2016·Granted Aug 16, 2016·8 cites·6 claims
- 3595US9067998B1Targeting PD-1 variants for treatment of cancerKYMAB LTD·Filed 2014·Granted Jun 30, 2015·20 cites·15 claims
- 3695US9062105B1Precision Medicine by targeting VEGF-A variants for treatment of retinopathyKYMAB LTD·Filed 2014·Granted Jun 23, 2015·14 cites·28 claims
- 3795US9040052B1Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatmentKYMAB LTD·Filed 2014·Granted May 26, 2015·11 cites·26 claims
- 3895US8980273B1Method of treating atopic dermatitis or asthma using antibody to IL4RAKYMAB LTD·Filed 2014·Granted Mar 17, 2015·23 cites·21 claims
- 3994US11399522B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2021·Granted Aug 2, 2022·2 cites·13 claims
- 4094US11396550B2Methods of treating comprising administering anti-OX40L antibodiesKYMAB LTD·Filed 2017·Granted Jul 26, 2022·4 cites·54 claims
- 4194US10966412B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2018·Granted Apr 6, 2021·11 cites·21 claims
- 4294US10654935B2Methods of treating SLE with anti-OX40L antibodiesKYMAB LTD·Filed 2016·Granted May 19, 2020·7 cites·13 claims
- 4394US9783593B2Antibodies, variable domains and chains tailored for human useKYMAB LTD·Filed 2013·Granted Oct 10, 2017·19 cites·18 claims
- 4494US9587030B2Anti-hOX40L antibodies, uses, and methodsKYMAB LTD·Filed 2016·Granted Mar 7, 2017·14 cites·21 claims
- 4594US9394568B2Methods of treating anaemiaKYMAB LTD·Filed 2015·Granted Jul 19, 2016·4 cites·30 claims
- 4694US9023359B1Targeting rare human PCSK9 variants for cholesterol treatmentKYMAB LTD·Filed 2014·Granted May 5, 2015·8 cites·28 claims
- 4794US9017678B1Method of treating rheumatoid arthritis using antibody to IL6RKYMAB LTD·Filed 2014·Granted Apr 28, 2015·12 cites·27 claims
- 4894US8999341B1Targeting rare human PCSK9 variants for cholesterol treatmentKYMAB LTD·Filed 2014·Granted Apr 7, 2015·11 cites·25 claims
- 4994US8951523B1Targeting rare human PCSK9 variants for cholesterol treatmentKYMAB LTD·Filed 2014·Granted Feb 10, 2015·9 cites·29 claims
- 5093US10669342B2Anti-OX40L antibodies and methods of treating graft versus host diseaseKYMAB LTD·Filed 2015·Granted Jun 2, 2020·7 cites·14 claims
Showing the top 50 of 198 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when KYMAB LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →